Avidity Biosciences
RNAM
#1865
Rank
S$14.45 B
Marketcap
S$93.58
Share price
0.00%
Change (1 day)
42.83%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Last known market cap: S$14.45 Billion

As of November 2026 Avidity Biosciences has a market cap of S$14.45 Billion. This makes Avidity Biosciences the world's 1865th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026S$14.45 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$215.71 B 1,392.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$130.34 B 801.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
S$2.29 B-84.10%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
S$6.96 B-51.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.25 B-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$1.05 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
S$14.04 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$4.95 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA